NanoRepro AG Logo

NanoRepro AG

ISIN: DE0006577109 | Ticker: NN6 | LEI: 3912008FCA63AGIMEV74
Sector: Health CareSub-Industry: Health Care Supplies
Country: Germany

About NanoRepro AG

Company Description

NanoRepro AG, based in Marburg an der Lahn, specializes in the development, manufacture and national and international distribution of medical self-tests and is primarily active in health planning and prevention.

The company addresses a rapidly growing market, which is characterized by the steadily increasing health awareness of the population and will continue to gain in importance in the coming years.

NanoRepro has 24 rapid tests in its portfolio and is continuously expanding it. Among others, the company has already established 2 pregnancy tests, a test for male fertility determination, a test for gastric health as well as a range of different allergy tests and tests for preventive health care on the market.

Year founded

2006

Served area

Worldwide

Headquarters

Untergasse 8, 35037 Marburg – Germany

Filings & Publications

2021

Report
Q1
H1
Q3
FY
Consolidated Report
GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
04.08.23 Jüngst, Lisa Board Buy EUR 45,880.06
02.08.23 Stiller, Dr. Olaf Supervisory board Buy EUR 21,964.00
02.08.23 Stiller, Dr. Olaf Supervisory board Buy EUR 9,670.30
02.08.23 Stiller, Johanna Close relation Buy EUR 5,625.00

Capital markets information

ISIN

DE0006577109

LEI

3912008FCA63AGIMEV74

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Supplies

Listed Stock Exchange

Frankfurt Stock Exchange

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.